Literature DB >> 23621961

Depression and cardiovascular disease.

Larkin Elderon1, Mary A Whooley.   

Abstract

Approximately one out of every five patients with cardiovascular disease (CVD) suffers from major depressive disorder (MDD). Both MDD and depressive symptoms are risk factors for CVD incidence, severity and outcomes. Great progress has been made in understanding potential mediators between MDD and CVD, particularly focusing on health behaviors. Investigators have also made considerable strides in the diagnosis and treatment of depression among patients with CVD. At the same time, many research questions remain. In what settings is depression screening most effective for patients with CVD? What is the optimal screening frequency? Which therapies are safe and effective? How can we better integrate the care of mental health conditions with that of CVD? How do we motivate depressed patients to change health behaviors? What technological tools can we use to improve care for depression? Gaining a more thorough understanding of the links between MDD and heart disease, and how best to diagnose and treat depression among these patients, has the potential to substantially reduce morbidity and mortality from CVD. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23621961     DOI: 10.1016/j.pcad.2013.03.010

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  41 in total

1.  Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.

Authors:  Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne
Journal:  Brain Behav Immun       Date:  2018-06-19       Impact factor: 7.217

2.  Depressive symptoms, functional measures and long-term outcomes of high-risk ST-elevated myocardial infarction patients treated by primary angioplasty.

Authors:  Leonida Compostella; Sonia Lorenzi; Nicola Russo; Tiziana Setzu; Caterina Compostella; Elia Vettore; Giambattista Isabella; Giuseppe Tarantini; Sabino Iliceto; Fabio Bellotto
Journal:  Intern Emerg Med       Date:  2016-07-12       Impact factor: 3.397

Review 3.  [Depression in old age, part 2 : Comorbidity and treatment].

Authors:  Dirk K Wolter
Journal:  Z Gerontol Geriatr       Date:  2016-02-11       Impact factor: 1.281

Review 4.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

Review 5.  Disturbed tryptophan metabolism in cardiovascular disease.

Authors:  H Mangge; I Stelzer; E Z Reininghaus; D Weghuber; T T Postolache; D Fuchs
Journal:  Curr Med Chem       Date:  2014-06       Impact factor: 4.530

6.  Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population.

Authors:  Michael J Bly; Stephan F Taylor; Gregory Dalack; Rodica Pop-Busui; Kyle J Burghardt; Simon J Evans; Melvin I McInnis; Tyler B Grove; Robert D Brook; Sebastian K Zöllner; Vicki L Ellingrod
Journal:  Bipolar Disord       Date:  2013-12-13       Impact factor: 6.744

7.  Antidepressant Medication Use and Its Association With Cardiovascular Disease and All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Richard A Hansen; Yulia Khodneva; Stephen P Glasser; Jingjing Qian; Nicole Redmond; Monika M Safford
Journal:  Ann Pharmacother       Date:  2016-01-18       Impact factor: 3.154

8.  Depressive symptoms do not discriminate: racial and economic influences between time-varying depressive symptoms and mortality among REGARDS participants.

Authors:  Deanna P Jannat-Khah; Yulia Khodneva; Kelsey Bryant; Siqin Ye; Joshua Richman; Ravi Shah; Monika Safford; Nathalie Moise
Journal:  Ann Epidemiol       Date:  2020-05-07       Impact factor: 3.797

9.  Exploring the excess mortality due to depressive symptoms in a community-based sample: The role of Alzheimer's Disease.

Authors:  Elvira Lara; Josep Maria Haro; Ming-Xin Tang; Jennifer Manly; Yaakov Stern
Journal:  J Affect Disord       Date:  2016-05-27       Impact factor: 4.839

10.  The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.

Authors:  Shipra Arya; Sujin Lee; Greg J Zahner; Beth E Cohen; Jade Hiramoto; Owen M Wolkowitz; Anjali Khakharia; Zachary O Binney; S Marlene Grenon
Journal:  J Vasc Surg       Date:  2018-03-24       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.